![]() |
|
|
Molecular Pharmacology, Vol 16, 1011-1018, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics
]Pyrene
1 Chemistry Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014 and
Department of Biological Chemistry, Medical School, The University of Michigan, Ann Arbor,
Michigan 48109
Purified forms of rabbit liver microsomal cytochrome P-450 (phenobarbital-inducible P-450LM2 and
-naphthoflavone-inducible P-450LMLM4), were examined for catalytic activity in
the conversion of the (-) and (+) enantiomers of trans-7,8-dihydroxy-7,8-dihydrobenzo-[a]pyrene to stereoisomeric, highly reactive and mutagenic 7,8-dlhydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo[
]pyrenes. In the reconstituted enzyme system, P-450LMLM4 from
both phenobarbital- and
-naphthoflavone-induced animals has much higher catalytic
activity than P-450LMLM2 with either enantiomer of the trans-7,8-diol. Both forms of the
cytochrome exhibit greater activity toward the (-) than the (+) isomer of the substrate,
but this is more striking with P-450LMLM4. The relative amounts of diol-epoxides formed
from either enantiomer of the substrate differ markedly with the form of the cytochrome
used. P-450LMLM2 gives somewhat more diol-epoxide I than diol-epoxide II with both
substrates. In contrast, P-450LMLM4 gives almost exclusively diol-epoxide I from the (-)trans-7,8-diol and more diol-epoxide II than diol-epoxide I from the (+)trans-7,8-diol. Thus,
P-450LMLM4 is highly stereospecific in oxygenating at the 9,10 double bond, regardless of the
absolute configuration of the hydroxyl groups at the 7 and 8 positions of the substrate.
Note:
ACKNOWLEDGMENTS
The authors wish to thank Sylvia B. Dahl for
purifying cytochrome P-450 and Barbara M. Michniewicz for purifying the reductase.
This article has been cited by other articles:
![]() |
J.-L. Fang, F. A. Beland, D. R. Doerge, D. Wiener, C. Guillemette, M. M. Marques, and P. Lazarus Characterization of Benzo(a)pyrene-trans-7,8-dihydrodiol Glucuronidation by Human Tissue Microsomes and Overexpressed UDP-glucuronosyltransferase Enzymes Cancer Res., April 1, 2002; 62(7): 1978 - 1986. [Abstract] [Full Text] [PDF] |
||||